1J·

Valuation Healthcare sector - Goldman Sachs

$XDWH (+1,03 %)
$XLV (+1,25 %)
$CSPX (-0,46 %)
$VUSA (-0,43 %)
$UNH (+0,27 %)
$OSCR


According to Goldman Sachs, healthcare is the only sector in the S& P 500 that is cheaper than the 10- and 30-year averages.


This is an extremely attractive risk/reward ratio and the coming months will be exciting.

attachment

$ELV (+0,95 %)
$CNC (+1,58 %)
$DHR (-0,22 %)
$SRT (-8,6 %)
$LLY (+1,37 %)
$NOVO B (+2,41 %)
$NVO (+2,16 %)
$ISRG (-0,82 %)
$JNJ (+0,99 %)
$ABBV (+0,44 %)
$PFE (+2,45 %)
$SAN (+0,9 %)
$MRK (+2,28 %)
$BMY (+2,07 %)
$TMO (+4,19 %)

9
5 Commentaires

image de profil
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
2
image de profil
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
1
image de profil
@Tenbagger2024 would expect a rotation from August. Tariffs on everything will be higher than expected, pharma will remain exempt as Trump cannot afford this. The requirement to produce in the USA in 1-2 years is still a long way off (current requirement) and many are already producing there (not counting preliminary products).
1
image de profil
If you define yourself as a long-term investor, you can definitely bag favorable entry prices here! The revaluation will come, especially when momentum is lower. So far I have bought $TMO $MRK $AZN. I think we will see more inflows here again from August.
1
image de profil
@Michey777 I see it the same way 👌
1
Participez à la conversation